Broker Research
April 24, 2025 / 09:30 IST
Reported Standalone quarterly numbers for Astec Lifesciences are:Net Sales at Rs 119.53 crore in March 2025 down 22.26% from Rs. 153.75 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 16.10 crore in March 2025 down 1528.08% from Rs. 0.99 crore in March 2024.
EBITDA stands at Rs. 6.30 crore in March 2025 down 57.26% from Rs. 14.74 crore in March 2024.
Astec Life shares closed at 765.00 on April 22, 2025 (NSE) and has given -28.43% returns over the last 6 months and -39.52% over the last 12 months.
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 119.53 | 93.86 | 153.75 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 119.53 | 93.86 | 153.75 | | EXPENDITURE | | Consumption of Raw Materials | 85.45 | 63.31 | 82.50 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -11.92 | -1.73 | 22.82 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.43 | 15.52 | 14.69 | | Depreciation | 11.59 | 11.42 | 9.02 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 26.04 | 22.50 | 21.03 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.07 | -17.15 | 3.69 | | Other Income | 0.78 | 1.89 | 2.03 | | P/L Before Int., Excpt. Items & Tax | -5.29 | -15.26 | 5.72 | | Interest | 10.40 | 9.92 | 6.68 | | P/L Before Exceptional Items & Tax | -15.69 | -25.18 | -0.96 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -15.69 | -25.18 | -0.96 | | Tax | 0.41 | 15.22 | 0.03 | | P/L After Tax from Ordinary Activities | -16.10 | -40.40 | -0.99 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -16.10 | -40.40 | -0.99 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -8.21 | -20.60 | -0.50 | | Diluted EPS | -8.21 | -20.60 | -0.50 | | EPS After Extra Ordinary | | Basic EPS | -8.21 | -20.60 | -0.50 | | Diluted EPS | -8.21 | -20.60 | -0.50 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
